Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Teva Branded Pharmaceutical Products R&D, Inc.”

9 pharma patents match "Teva Branded Pharmaceutical Products R&D, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 9
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 9 pharmaceutical patents matching "Teva Branded Pharmaceutical Products R&D, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

9 results for “Teva Branded Pharmaceutical Products R&D, Inc.” · 30,257 patents in full index Clear search

  1. US 10653704

    Inhalable formulation

    Teva Branded Pharmaceutical Products R&D, Inc. · Granted May 19, 2020 · Expires May 14, 2040

    granted
  2. US 10188811

    Nasal spray device

    Teva Branded Pharmaceutical Products R&D, Inc. · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted
  3. US 10034866

    Inhalable medicament comprising tiotropium

    Teva Branded Pharmaceutical Products R&D, Inc. · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted
  4. US 9980904

    Dry powder formulation

    Teva Branded Pharmaceutical Products R&D, Inc. · Granted May 29, 2018 · Expires May 24, 2038

    granted
  5. US 9707295

    Inhalable medicament

    Teva Branded Pharmaceutical Products R&D, Inc. · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted
  6. US 9655969

    Inhalable medicament comprising tiotropium

    Teva Branded Pharmaceutical Products R&D, Inc. · Granted May 23, 2017 · Expires May 18, 2037

    granted
  7. US 9415008

    Dry powder inhaler

    Teva Branded Pharmaceutical Products R&D, Inc. · Granted Aug 16, 2016 · Expires Aug 11, 2036

    granted
  8. US 9364540

    Inhalable medicament

    Teva Branded Pharmaceutical Products R&D, Inc. · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  9. US 9066957

    Dry powder inhaler

    Teva Branded Pharmaceutical Products R&D, Inc. · Granted Jun 30, 2015 · Expires Jun 25, 2035

    granted